Virological response and safety outcomes in therapy-nai{dotless}̈ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study>

  • Robert G. Gish
  • , Sanjeev Arora
  • , K. Rajender Reddy
  • , David R. Nelson
  • , Christopher O'Brien
  • , Yi Xu
  • , Brian Murphy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)51-59
Number of pages9
JournalJournal of Hepatology
Volume47
Issue number1
DOIs
StatePublished - Jul 2007
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology

Keywords

  • Anemia
  • Hepatitis C
  • Phase 2 study
  • Ribavirin
  • Safety
  • Taribavirin
  • Viramidine

Cite this